Michael D Story Selected Research

Michael D Story Research Topics

Disease

37	Neoplasms (Cancer) 10/2023 - 11/2002
10	Squamous Cell Carcinoma of Head and Neck 01/2022 - 11/2002
8	Head and Neck Neoplasms (Head and Neck Cancer) 10/2023 - 04/2011
8	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2021 - 06/2007
6	Hypoxia (Hypoxemia) 01/2022 - 04/2009
5	Lung Neoplasms (Lung Cancer) 09/2015 - 10/2006
3	Carcinogenesis 01/2019 - 10/2010
2	Glioblastoma (Glioblastoma Multiforme) 01/2019 - 04/2009
2	Second Primary Neoplasms (Neoplasms, Second) 01/2018 - 06/2013
2	Sickle Cell Anemia (Hemoglobin S Disease) 01/2016 - 04/2012
2	Lung Injury 06/2015 - 07/2014
2	Ataxia Telangiectasia (Louis Bar Syndrome) 04/2012 - 04/2004
2	Lymphoma (Lymphomas) 01/2011 - 11/2009
1	Hepatocellular Carcinoma (Hepatoma) 01/2022
1	Mucositis 12/2021
1	Adenocarcinoma 12/2021
1	Neuroinflammatory Diseases 01/2021
1	Fanconi Anemia (Fanconi's Anemia) 01/2020
1	Glioma (Gliomas) 01/2019
1	Brain Neoplasms (Brain Tumor) 01/2019
1	Colonic Neoplasms (Colon Cancer) 01/2019
1	Hyperplasia 09/2015
1	Hemoglobinopathies 01/2014
1	Leukemia 01/2014
1	Genomic Instability 03/2013
1	Chromosome Aberrations (Chromosome Abnormalities) 03/2013
1	Hypertension (High Blood Pressure) 01/2013
1	Pheochromocytoma 01/2013
1	Radiation Injuries (Radiation Sickness) 05/2012
1	Wounds and Injuries (Trauma) 05/2012
1	Urinary Bladder Neoplasms (Bladder Cancer) 12/2011
1	Chromosome Breakage 07/2011

Drug/Important Bio-Agent (IBA)

8	DNA (Deoxyribonucleic Acid)IBA 10/2021 - 02/2004
6	MicroRNAs (MicroRNA)IBA 01/2022 - 05/2009
6	Biomarkers (Surrogate Marker)IBA 01/2022 - 07/2010
5	Proteins (Proteins, Gene)FDA Link 05/2019 - 04/2011
4	IonsIBA 01/2022 - 10/2010
3	Glutathione (Reduced Glutathione)IBA 12/2021 - 11/2009
3	RNA (Ribonucleic Acid)IBA 01/2020 - 03/2011
3	Messenger RNA (mRNA)IBA 01/2019 - 05/2009
3	CarbonIBA 01/2019 - 01/2018
3	GlobinsIBA 01/2016 - 04/2012
2	AntibodiesIBA 10/2023 - 04/2011
2	Protons (Proton)IBA 01/2019 - 01/2016
2	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 01/2019 - 04/2011
2	Small Interfering RNA (siRNA)IBA 01/2014 - 12/2011
2	Indicators and Reagents (Reagents)IBA 01/2013 - 11/2002
2	Phosphotransferases (Kinase)IBA 04/2012 - 10/2006
2	N- (5- (((5- (1,1- dimethylethyl)- 2- oxazolyl)methyl)thio)- 2- thiazolyl)- 4- piperidinecarboxamideIBA 10/2009 - 04/2009
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 06/2007 - 10/2006
2	ErbB Receptors (EGF Receptor)IBA 06/2007 - 10/2006
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 10/2023
1	CalreticulinIBA 10/2023
1	HMGB1 Protein (HMG1)IBA 10/2023
1	Oxygen (Dioxygen)IBA 01/2022
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 12/2021
1	ThioredoxinsIBA 12/2021
1	Superoxides (Superoxide)IBA 12/2021
1	CatalaseIBA 12/2021
1	Superoxide DismutaseIBA 12/2021
1	Auranofin (Ridaura)FDA Link 12/2021
1	avasopasem manganeseIBA 12/2021
1	Buthionine SulfoximineIBA 12/2021
1	Long Noncoding RNAIBA 06/2020
1	Culture MediaIBA 01/2020
1	ProteomeIBA 05/2019
1	Immune Checkpoint InhibitorsIBA 01/2019
1	Proto-Oncogene Proteins c-metIBA 01/2019
1	Radiation-Sensitizing AgentsIBA 01/2019
1	Cetuximab (Erbitux)FDA Link 11/2017
1	Replication Protein AIBA 11/2017
1	Fetal Hemoglobin (Hemoglobin F)IBA 01/2016
1	Codon (Codons)IBA 01/2016
1	CytokinesIBA 06/2015
1	Hemoglobins (Hemoglobin)IBA 01/2014
1	Cisplatin (Platino)FDA LinkGeneric 03/2013
1	CamptothecinIBA 03/2013
1	Lamin Type A (Lamin A)IBA 03/2013
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 03/2013
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2013
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2013
1	Chromogranin AIBA 01/2013
1	Hormones (Hormone)IBA 01/2013
1	Nerve Growth Factor (NGF)IBA 01/2013
1	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2013
1	Epinephrine (Adrenaline)FDA LinkGeneric 01/2013
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 04/2012
1	Transcription Factors (Transcription Factor)IBA 04/2012
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 12/2011
1	cyclophilin BIBA 12/2011
1	Peptidylprolyl Isomerase (Prolyl Isomerase)IBA 12/2011
1	Cyclin DIBA 03/2011
1	Cyclin D1IBA 03/2011

Therapy/Procedure

24	Radiotherapy 01/2022 - 11/2002
11	Therapeutics 10/2023 - 10/2009
5	Drug Therapy (Chemotherapy) 01/2022 - 07/2010
3	Immunotherapy 10/2023 - 01/2018
2	Photochemotherapy (Photodynamic Therapy) 10/2023 - 01/2021
1	Precision Medicine 01/2018
1	Aftercare (After-Treatment) 09/2016